21 November 2012
Scientists have developed a nanoparticle that could improve chemotherapy for childhood cancer.
Research published in the journal Chemical Communications, found that the nanoparticle could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five.
The non-toxic particle is able to deliver and release nitric oxide (NO) to specific cancer cells in the body.
It is a particularly significant finding given that neuroblastoma treatment often leaves survivors with ongoing problems due to the high doses of chemotherapy drugs that are required for treatment.
Co-author Dr Cyrille Boyer, from the University of New South Wales, said: "When we injected the chemo drug into the neuroblastoma cells that had been pre-treated with our new nitric oxide nanoparticle we needed only one-fifth of the dose.
"By increasing the effectiveness of these chemotherapy drugs by a factor of five, we could significantly decrease the detrimental side-effects to healthy cells and surrounding tissue."
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.